a number of other arthritogenic organisms in a heterogeneous cohort of early synovitis patients and to examine the potential diagnostic and prognostic value of the detection of elevated antiProteus antibodies. We also measured antibodies to immunoglobulin (Ig) G damaged by advanced glycation end-products (AGE) [19] , and found that the RA patients with this reactivity were also positive for the anti-Proteus and anti-E. coli response. Our data suggest that recent infections with Proteus and or E. coli, as measured by IgM elevations, can be detected in patients with seropositive RA early in their disease.
Materials and methods

Patients
A cohort of 246 patients with inflammatory arthritis for less than 1 yr involving one or more swollen joints was enrolled into an early synovitis study at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (protocol 94-AR-0194). Patients had persistent synovitis of at least one peripheral joint for more than 6 weeks. Patients with traumatic, septic and crystalinduced arthritis were excluded. As previously reported [19] , the patients were evaluated clinically, serologically and radiographically at the initial visit, and later at 6 weeks, 6 months and 1 yr. Diagnosis was established at the end of year 1. The number of swollen joints was determined by evaluating for the presence of effusion or synovial thickening or both in 66 peripheral joints, excluding hip joints. Anteroposterior and lateral radiographs of the hands and feet were taken at the initial visit and at the 1-yr follow-up visit and were evaluated for the presence of erosions. Erosions were defined as the presence of radiographic erosions of any involved joint, detected by 1 yr on either the initial or the 1-yr follow-up radiographs. The American College of Rheumatology (ACR) criteria for RA [20] , and the European Spondylarthropathy Study Group (ESSG) criteria for spondylarthropathy [21] were applied to each member of the cohort based on the clinical, radiographic and laboratory data obtained. All patients not fulfilling either set of criteria were classified as having undifferentiated arthropathy (UA) for the purposes of this study.
This study was approved by the local medical ethics committee and patients gave their written informed consent.
Measurement of antibodies to P. mirabilis and other microbial organisms
Serum taken at the patients' initial visit was assayed by enzymelinked immunosorbent assay (ELISA) for antibodies to microbial organisms, including P. mirabilis, as previously described [15] . Eleven strains of P. mirabilis representing the 11 commonest O serotypes of strains associated with a P. mirabilis urinary tract infection [22] , namely serotypes O3, O6, O10, O11, O13, O23, O24, O27, O28, O29 and O30, were each cultured overnight at 37 C on plates of cystine lactose electrolyte-deficient (CLED) medium (CM 301; Oxoid, Basingstoke, UK). Equal numbers of cells of all the 11 different O serotypes were pooled together and used as the source of Proteus antigen. The cells of each serotype were harvested and suspended in phosphate-buffered saline (PBS) pH 7.2 containing sodium azide 0.04% (PBS-Az) and then washed in this solution. The washed cells were resuspended in PBS-Az to an optical density (OD) (550 nm) of 1 and stored as a standard suspension at 4 C. Equal volumes of each of the standard 11 O serotype suspensions of P. mirabilis were then pooled. Aliquots (100 l) of a 1 in 10 dilution of the pooled standard suspension in PBS-Az were added to flat-bottomed wells of microtitration plates (Maxisorb F8; Nunc, Nottingham, UK), which were covered and left overnight at room temperature. The contents of the wells were then discarded and the wells washed three times in water. PBS-Az containing Tween-20 0.05% (PBST) supplemented with bovine serum albumin 0.05% (200 l) was added to each well and incubated for 1 h at room temperature. The contents of the wells were then discarded and the wells washed three times in water. One hundred microlitres of either serum diluted in PBST (for IgG, dilution was 1 in 1000; for both IgA and IgM, dilution was 1 in 100) or of PBST alone (control) was added to each well in triplicate and the plates were incubated for 2 h at room temperature. All sera were assayed for anti-Proteus antibodies with the laboratory blinded to the clinical status. The well contents were then discarded and the wells washed three times in water. Two hundred microlitres of goat anti-human alkaline phosphatase-conjugated IgG or IgA or IgM (Sigma, St Louis, MO, USA) diluted 1 in 1000 in PBST was added to the each well. After incubation for 1.5 h at room temperature, the contents of the wells were discarded and the wells washed three times in water. Two hundred microlitres of p-nitrophenyl phosphate 1 mg/ml in substrate buffer (100 mM sodium bicarbonate, 1 mM magnesium chloride, pH 10.2) was added to each well. After incubation at 37 C above the mean of a reference group of normal subjects; Salmonella IgG, >10 U; Salmonella IgM, >20 U; Salmonella IgA, >20 U; Shigella IgG, >20 U; Yersinia IgG, >3 S.D. above the mean of a reference group of normal subjects; Yersinia IgM, >3 S.D. above the mean of a reference group of normal subjects; Yersinia IgA, >3 deviation above the mean of a reference group of normal subjects; parvovirus B19 IgG, >10 EIA units; parvovirus B19 IgM, >10 EIA units.
Detection of RF
RF was measured by nephelometry. In addition, in a subset of patients in one experiment the RF was also assayed by an alternative method in which 50 l of serum diluted 20-fold in glycine-saline buffer, pH 8.2, was mixed with 50 l of RF latex reagent (IgG-coated latex particles; Biostat Diagnostics, Stockport, UK), rocked for 2 min and then examined for agglutination of the latex particles. Positive and negative RF sera were included as controls in each batch of tests. Agglutination indicated the serum had an RF content of !20 IU/ml. Doubling dilutions of such positive sera were retested. The RF concentration was equal to the highest dilution of serum giving visible agglutination of the latex particles [15] . RF was removed from sera by repeated adsorption with latex beads coated in human IgG, and centrifugation to deposit the latex beads until the RF level of the serum supernatant was 520 IU/ml. The supernatant was then measured for IgM antibodies to P. mirabilis by ELISA.
Measurement of antibodies to IgG-AGE
IgM and IgA anti-IgG-AGE antibodies were detected in serum or plasma by ELISA as previously described [19, 23, 24] , the testing laboratory being blinded to the diagnosis. IgGs of all four subclasses, which were fully glycated in vitro, were used at a concentration of 2 g/ml (100 l/well) to coat the wells of an ELISA plate (EIA; ICN, Montreal, QC, Canada). After washing the plates, 100 l of the sera or plasma diluted 1 in 1000 were applied in duplicate to each well, and were incubated in the AGEmodified Ig-coated wells for 2 h at 37 C. After washing the plates in PBS/0.1% Tween 20, the bound antibodies were detected with peroxidase-conjugated F(ab 0 )2 fragments of anti-human IgM, or IgA (Jackson Immunolabs) diluted 1 in 10 000 in PBS/0.1% Tween. To follow the reactivity over time and to maintain consistent results, a control serum from a normal individual (approximately the mean reactivity) and a positive control were tested each time the assay was performed. After washing the plates three times with PBS/0.1% Tween, 100 l of the substrate o-phenylene diamine (2 mM in 0.02 M citric acid, 0.05 M Na 2 HPO4, 0.012% H 2 O 2 ) was added. The reaction was stopped by the addition of 4 M H 2 SO 4 approximately 30 min later. The OD 492 (reference OD 690 ; the reference wavelength is used as it gives better signal-to-noise ratios for the assay) was measured, using an ELISA plate reader (SLT Lab Instruments). Cut-off values were determined from the sera of 20 normal controls, and were the mean þ 2 S.D.
HLA typing
Patients were HLA-typed for MHC class I and DR alleles by the molecular polymerase chain reaction-sequence specific primer method using sequence-specific primers, as previously described [25] .
Statistical analysis
Statistical analyses were performed using SAS (Bethesda, MD, USA) and EpiInfo 16 statistical software for parametric and non-parametric comparisons between groups (Centers for Disease Control and Prevention, Atlanta; http://www.cdc.gov/epiinfo). Patient groups were compared using parametric and nonparametric statistics. Analysis of variance (ANOVA) and the Kruskal-Wallis test were used for continuous variables, and the 2 test for proportions. Bonferroni correction was made for multiple comparisons, where appropriate.
Results
As previously reported, of the 246 patients with synovitis of recent onset in the cohort, 113 (46%) met the ACR criteria for RA [19] . Of the 246 patients, 43 (17%) fulfilled the ESSG criteria for a spondyloarthropathy (SpA), and 90 (37%) patients had undifferentiated arthritis (UA), respectively. The SpA group appeared atypical (Table 1) , but this may reflect the fact that the ESSG criteria do not discriminate as well in an early synovitis cohort. Table 1 shows the demographic and clinical data of the patients studied. Radiographic erosions were either present at entry or developed during the year of follow-up. Of the patients with RF-positive RA, 40% had erosions that were either present at study entry or developed within the year of study follow-up, and 37% of RF-negative RA patients had erosions either at study entry or at the 1 yr follow-up evaluation. By comparison, only 12 and 15%, respectively, of patients with SpA or UA had radiographic erosions at 1 yr. As expected, a significantly larger number of patients with RA received treatment with prednisolone and/or DMARDs (P50.005 and P50.0001 respectively). All patient groups received similar levels of NSAID therapy. Anti-IgA and IgM P. mirabilis-specific serum antibody titres are elevated in patients with RF-positive RA Proteus antibodies associate with markers of disease severity only in patients with RA
The results in Table 2 Because of the correlation between IgM anti-Proteus antibody levels and RF, it was necessary to examine whether the IgM RF was causing a false-positive result in the Proteus assay. Therefore, sera from 12 patients with the highest levels of RF who also had high anti-Proteus IgM antibody titres were selected and RF was removed by repeated absorption with latex beads coated with human IgG. In 10 patients' sera this resulted in no significant drop in the anti-Proteus IgM antibody level. In one patient's serum (patient 8) there was a significant drop in anti-Proteus IgM titre after removal of RF (Table 3) . To further exclude the possibility that the Proteus assay was measuring the RF, the mean OD for the anti-Proteus IgM antibody of the RF positive patients was used as an arbitrary cut-off level to define highpositive anti-Proteus IgM patients. This new category comprised 58 patients, of whom 34 (59%) were patients with RA and 24 (41%) were patients with other forms of arthritis. Of the patients with high anti-Proteus levels, 38 (66%) were RF-positive and 20 (34%) patients were RF-negative. Similar results were obtained when anti-Proteus positivity was defined on the basis of elevated IgA levels or a combination of either IgA or IgM levels (data not shown). If RF was causing false-positive measures of IgM antiProteus, we would anticipate that all RF-positive individuals would be IgM anti-Proteus-positive, and this was not the case. Of the 41 RA patients with the lowest levels of IgM anti-Proteus antibodies, 11 had markedly elevated RF, with levels of 80-598 IU/ml. 
Anti-Proteus IgM and IgA antibodies were highest in sera positive for RF and anti-IgG-AGE antibodies
Because the immune response to IgG damaged by AGE has been shown to be linked to the RF response [23, 24] in other cohorts, it was of interest to divide the patients in the present cohort according to those that were positive for both RF and anti-IgG-AGE antibodies; those positive for the RF alone; those positive for anti-IgG-AGE antibodies alone; and those negative for both RF and anti-IgG-AGE antibodies. Table 4 summarizes the results obtained from this stratified analysis. Anti-Proteus IgM and IgA antibody levels were more significantly elevated in patients who were positive for both RF and anti-IgG-AGE antibodies than in any of the other patient groups (Fig. 2) . In contrast, anti-Proteus IgG antibody levels did not differ significantly in the different groups.
Anti-IgM E. coli-specific antibody titres are observed in patients with RF-positive RA
We investigated the immune response to E. coli, the principal bacterium associated with bacteruria in the population at large. As can be seen from 2 ) fragments of the anti-IgM used in the ELISA assay we had lowered the possibility of false positives caused by the RFs. Indeed, several individuals with very high RF titres were negative for IgM anti-E. coli antibodies. There was a significant correlation between the IgM and IgA anti-E. coli responses, with r ¼ 0.55; P50.0001, which is expected given the mucosal site of infection by these bacteria. There was no correlation observed between the IgA anti-E. coli response and the IgM RF.
Interestingly, there was a significant correlation between the IgM anti-P. mirabilis response and the IgM anti-E. coli response (r ¼ 0.49; P ¼ 0.0001), but only in the RF-positive RA patient subgroup, linking them as infectious organisms that colonize the mucosal surfaces. There was no significant correlation between the IgA anti-E. coli and IgA anti-P. mirabilis responses (r ¼ 0.073). The elevations in the IgM response may suggest recent infections. As with the Proteus infections, there was a highly significant correlation between the IgM response to E. coli and the presence of anti-IgG-AGE antibodies [median (95% CI) for anti-E. coli response in those that had anti-IgG-AGE antibodies, 0.724 (0.662-1.133); in those that lacked anti-IgG-AGE antibodies, 0.288 (0.347-0.652); P ¼ 0.0003]. There were no significant correlations between any disease activity scores, markers of inflammation or erosions or the presence of the shared epitope with the IgM immune response to E. coli. There was a weak association between the IgA anti-E. coli response and the use of prednisolone (r ¼ 0.245; P ¼ 0.0112). However, prednisolone use did not affect the IgM anti-E. coli response or the IgA or IgM anti-P. mirabilis response. We investigated the frequency of the antibody response to either or both of E. coli and P. mirabilis in the three patient groups, and found that 55% of RA patients had an IgM response to either or both bacteria, whereas the frequencies were lower in both the SpA (36%) and UA (34%) patients. Interestingly, in the RA patients there was a trend for elevated IgM responses being higher in females (39/70 or 56%) compared with males (18/37 or 49%). This is consistent with the fact that bacteruria and/or urinary tract infection is much more common in females than males.
Differences in antibody responses to other potential arthritogenic pathogens were not seen in the different disease groups Analysis of the presence of antibodies to other potential arthritogenic pathogens, including C. trachomatis (IgG and IgM), C. jejuni (total Ig), S. typhi (IgG, IgM, IgA), S. flexneri (total Ig), Y. enterocolitica (IgG, IgM, IgA), and parvovirus B19 (IgG, IgM), was made to determine whether antibody titre differences could be detected in the different disease groups: RF-positive RA, RF-negative RA, SpA and UA. No significant differences in the frequency of antibody presence or levels (data not shown for antibody levels) were observed for any of the anti-pathogen antibodies listed (Table 6 ). Anti-AGE antibody titres were only determined for only 237 patients of this cohort.
*P ¼ 0.0015; **P ¼ 0.009; comparisons by ANOVA were made between all four groups.
Discussion
Multiple cross-sectional studies in various ethnic populations have demonstrated that elevated antibody titres to P. mirabilis are seen in patients with RA [6] [7] [8] [9] [10] [11] [12] [13] . However, the patients examined in these studies had longstanding disease, and control subjects were either healthy or comprised patients with reactive arthritis or osteoarthritis. Thus, the patient populations were not appropriate for the evaluation of the diagnostic and prognostic significance of raised antibody production to P. mirabilis. We therefore examined the prevalence of anti-Proteus antibodies and their prognostic and diagnostic value in a diverse cohort of patients with recent onset of inflammatory arthritis.
In our cohort of patients with recent onset of synovitis, we demonstrate an association between RF-positive RA and anti-Proteus antibodies, specifically IgM and IgA but not IgG. We also examined the titres of the IgG anti-Proteus antibodies (data not shown) and there was no significant association found in this early synovitis cohort for the different patient groups or subgroups, unlike what was reported previously [6, 9] . Because IgG has a long half-life in serum (about a month) compared with IgM (about a week), it is not as reflective as the IgM levels of acute changes. Although the detection of IgM anti-Proteus antibodies could indicate a recent infection, elevations of both IgM and IgA antibodies are associated with an immune response in the mucosa. Elevations of both IgA and IgM in our patient cohort may therefore reflect an infection at a mucosal surface. Since patients from all groups had similar levels of anti-P. mirabilis IgG antibodies, it is evident that most of the individuals in the cohort had previously encountered this ubiquitous bacterium.
Since both P. mirabilis and E. coli are indigenous enterobacteria that inhabit our colons, a perturbation at that site could stimulate the antibody response. However, it also may be that the elevated serum levels of these antibodies in patients with RA may reflect an asymptomatic bacteruria. Indeed, it has been shown that P. mirabilis can be isolated more frequently from the urinary tract of women and men with RA than from controls [15, 17] . Furthermore, a significant positive correlation (r ¼ 0.714) between anti-Proteus antibody levels in the serum and Proteus colonyforming units in the urine of RA patients has been reported [17] . Of RA patients with bacteria in the urine, P. mirabilis was twice as frequently present as E. coli, and represented 52% of the infections [15] . This is in contrast to urinary tract infections in the population at large, where E. coli is the most frequent pathogen [26] . These bacteriurial infections in the patients with RA were asymptomatic [17] .
An examination of the E. coli immune response in our cohort indicated that the levels of all three isotypes were very similar in the patient groups, consistent with previous reports [11, [27] [28] [29] [30] , only the IgA anti-E. coli response being higher in the RA patients when compared with the undifferentiated arthritis group in the present study. We did find, however, a significant elevation in the IgM response to E. coli in the subgroup of early RA patients that were RF-positive. Senior et al. [7] previously reported a slight elevation of antibodies to E. coli, Klebsiella and Pseudomonas in RF-positive RA patients over that found in RF-negative RA patients with longstanding disease, but the differences did not reach statistical significance, whereas the difference between the anti-Proteus antibody response between the RFpositive and the RF-negative RA patients in that study was highly significant. Individuals with a compromised mucosal immune response may be at higher risk of bacteruria or recurrent urinary tract infection, and this might be a predisposing factor for RA. It is interesting that we detected twofold elevated levels of IgM, indicating recent infection with both bacteria in patients with RA, compared with the other patient groups. Patients with RA who have secondary Sjo¨gren's syndrome (SS) have been reported to have a significant increase in urinary tract infection: 35% compared with 4% in RA patients without SS [31] . A number of these SS patients had a history of recurrent urinary tract infection, but the infecting bacteria were not identified. In the present study, the patients were not systematically evaluated for the presence of SS.
It appears that the RF-positive subgroup of RA patients is particularly associated with elevated levels of anti-P. mirabilis IgM and IgA antibodies. This is consistent with a previous report [7] . We now extend this to elevated levels of IgM anti-E. coli. From the adsorption studies, this association with RF does not appear to be a result of a false-positive anti-P. mirabilis antibody analysis, consistent with a previous study [32] . Indeed many RF-positive patients were negative for antibodies to P. mirabilis. Many infections, bacterial, viral and parasitic, are associated with an RF response [33] . Recently it has been shown that efficient triggering of RF B cells by an immune complex (IC) containing CpG DNA required the co-ligation of surface RF and toll-like receptor-9 (TLR9) [34, 35] . The toll-like receptors [36] expressed on the B-cell surface or on the endosome can recognize several different bacterial products, such as lipopolysaccharide, peptidoglycan and CpG DNA. These receptors play an important role in the host's innate immune response and can contribute to the inflammatory response. It is possible that IgG-coated P. mirabilis or IgG-coated E. coli containing a number of different pathogenassociated molecules could trigger one or more of the toll-like receptors expressed by B cells and, together with the cross-linking of the RF expressed on the B cell, lead to the activation of RF-positive B cells.
Since it appears that B-cell activation is an outcome of infection by one of these Gram-negative bacteria, particularly in those susceptible to RA, it is possible that the link is due to a bacterial product that directly stimulates B cells. This might be OmpA, a 39-kDa outer membrane protein of P. mirabilis, which is a murine B-cell mitogen [37] . Interestingly, a previous study has shown that lipopolysaccharide can stimulate RF production in mice [38] .
The striking association of the anti-Proteus and the anti-E. coli response and IgM antibodies to IgG that were damaged by AGE, however, is novel. It is likely that these bacterial infections, even when subclinical, can stimulate a local inflammatory response, which could lead to IgG damage. We have shown previously that the anti-IgG-AGE response is linked to the RF response both in this cohort and in others [19, 23, 24] .
It was previously proposed that molecular mimicry might explain the association between Proteus infection and RA. It had been suggested that an extra-articular infection might trigger arthritis through the mimicry of two different sets of bacterial proteins and host proteins [39] . The mimicked proteins postulated to play a role included the epitope motif EQRRAA of HLA DRB1*0401, which is similar to the motif ESRRAL found in P. mirabilis haemolysin, and the epitope LRREI on type XI collagen shared with P. mirabilis urease [18, 35, 40, 41] . There is as yet neither conclusive epidemiological data nor direct proof that these bacteria or bacterial proteins induce arthritis. Moreover, in the present study no association was found between the shared HLA epitope linked to RA and the presence of elevated levels of P. mirabilis antibodies.
The possibility of other potentially arthritogenic bacteria playing a role in the development of early synovitis in the cohort was investigated, but there was no evidence that prior infection with any of these was more prevalent in the RA group with and without RF than in the other groups.
Our study indicates that, in patients with RA of less than 1 yr, elevated levels of anti-Proteus IgM and IgA and anti-E. coli IgM antibodies can be detected. Since IgG antibodies specific for these bacteria are also present, we cannot conclude that it is a primary infection that is associated with the onset of RA. Rather, it may be that individuals who develop RA have a propensity for recurrent subclinical bacterial infections, but how this relates to RA pathogenesis is not known as yet. In the case of the E. coli infections in RA, prednisolone use may be a contributing factor that needs to be considered. It is of interest that the anti-Proteus IgA but not the anti-E. coli antibodies appeared to be of some clinical significance, because higher levels of such antibodies were detected in individuals who had erosions compared with those that did not. In addition, there was a weak association of the IgA but not the IgM anti-Proteus antibodies with ESR and both total joint and swollen joint counts. The active inflammation induced by the bacterial infection may be important in the light of the association with anti-IgG-AGE antibodies. How the P. mirabilis or even the E. coli infection or the antibodies, or both, contribute to the disease process is still unresolved, but such infections do appear to be an early event in the disease course of seropositive RA. 
